Sino-American Shanghai Squibb Pharmaceuticals

Sino-American Shanghai Squibb Pharmaceuticals (SASS) is a landmark joint venture established in 1982 between Bristol Myers Squibb and Shanghai Pharmaceutical (Group) Co., Ltd. As the first Sino-American pharmaceutical joint venture in China, it has played a pivotal role in introducing modern Western medicine and international manufacturing standards to the Chinese market. The company specializes in the production and commercialization of high-quality pharmaceuticals across several therapeutic areas, including oncology, cardiovascular health, immunology, and infectious diseases. SASS operates a significant manufacturing base in Shanghai and remains a core component of Bristol Myers Squibb's strategic presence and supply chain in China.